Kura Oncology (KURA) Tops Q2 EPS by 1c

Kura Oncology (NASDAQ: KURA) reported Q2 EPS of ($0.53), $0.01 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Independent Bank receives regulatory approval for HCB Financial acquisition
• Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML